nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2C19—Progesterone—uterine cancer	0.131	0.304	CbGbCtD
Felbamate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0954	0.222	CbGbCtD
Felbamate—CYP2E1—Etoposide—uterine cancer	0.0933	0.217	CbGbCtD
Felbamate—CYP3A4—Progesterone—uterine cancer	0.0632	0.147	CbGbCtD
Felbamate—CYP3A4—Etoposide—uterine cancer	0.0283	0.0657	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—uterine cancer	0.0193	0.0448	CbGbCtD
Felbamate—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00039	0.000684	CcSEcCtD
Felbamate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000389	0.000682	CcSEcCtD
Felbamate—Increased appetite—Doxorubicin—uterine cancer	0.000388	0.00068	CcSEcCtD
Felbamate—Affect lability—Epirubicin—uterine cancer	0.000388	0.00068	CcSEcCtD
Felbamate—Migraine—Epirubicin—uterine cancer	0.000388	0.00068	CcSEcCtD
Felbamate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.000677	CcSEcCtD
Felbamate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000385	0.000676	CcSEcCtD
Felbamate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000383	0.000672	CcSEcCtD
Felbamate—Renal impairment—Doxorubicin—uterine cancer	0.000383	0.000672	CcSEcCtD
Felbamate—Malaise—Etoposide—uterine cancer	0.000381	0.000669	CcSEcCtD
Felbamate—Dermatitis bullous—Doxorubicin—uterine cancer	0.000381	0.000669	CcSEcCtD
Felbamate—Face oedema—Epirubicin—uterine cancer	0.00038	0.000667	CcSEcCtD
Felbamate—Leukopenia—Etoposide—uterine cancer	0.000379	0.000664	CcSEcCtD
Felbamate—Purpura—Doxorubicin—uterine cancer	0.000378	0.000663	CcSEcCtD
Felbamate—Abdominal pain—Dactinomycin—uterine cancer	0.000377	0.000662	CcSEcCtD
Felbamate—Body temperature increased—Dactinomycin—uterine cancer	0.000377	0.000662	CcSEcCtD
Felbamate—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000376	0.000661	CcSEcCtD
Felbamate—Cardiac arrest—Epirubicin—uterine cancer	0.000374	0.000657	CcSEcCtD
Felbamate—Hypoglycaemia—Doxorubicin—uterine cancer	0.000373	0.000655	CcSEcCtD
Felbamate—Cardiac failure—Doxorubicin—uterine cancer	0.000373	0.000655	CcSEcCtD
Felbamate—Mood swings—Epirubicin—uterine cancer	0.000373	0.000655	CcSEcCtD
Felbamate—Ataxia—Epirubicin—uterine cancer	0.00037	0.00065	CcSEcCtD
Felbamate—Cough—Etoposide—uterine cancer	0.000369	0.000648	CcSEcCtD
Felbamate—Dehydration—Epirubicin—uterine cancer	0.000366	0.000643	CcSEcCtD
Felbamate—Hyponatraemia—Doxorubicin—uterine cancer	0.000366	0.000642	CcSEcCtD
Felbamate—Hypertension—Etoposide—uterine cancer	0.000365	0.000641	CcSEcCtD
Felbamate—Diplopia—Doxorubicin—uterine cancer	0.000364	0.000639	CcSEcCtD
Felbamate—Osteoarthritis—Doxorubicin—uterine cancer	0.000364	0.000639	CcSEcCtD
Felbamate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000363	0.000637	CcSEcCtD
Felbamate—Chest pain—Etoposide—uterine cancer	0.00036	0.000632	CcSEcCtD
Felbamate—Affect lability—Doxorubicin—uterine cancer	0.000359	0.000629	CcSEcCtD
Felbamate—Migraine—Doxorubicin—uterine cancer	0.000359	0.000629	CcSEcCtD
Felbamate—Hypokalaemia—Epirubicin—uterine cancer	0.000358	0.000629	CcSEcCtD
Felbamate—Discomfort—Etoposide—uterine cancer	0.000356	0.000624	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000355	0.000622	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000355	0.000622	CcSEcCtD
Felbamate—Face oedema—Doxorubicin—uterine cancer	0.000352	0.000617	CcSEcCtD
Felbamate—Gastritis—Epirubicin—uterine cancer	0.000348	0.000611	CcSEcCtD
Felbamate—Confusional state—Etoposide—uterine cancer	0.000348	0.000611	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000347	0.000609	CcSEcCtD
Felbamate—Muscular weakness—Epirubicin—uterine cancer	0.000347	0.000609	CcSEcCtD
Felbamate—Cardiac arrest—Doxorubicin—uterine cancer	0.000346	0.000608	CcSEcCtD
Felbamate—Anaphylactic shock—Etoposide—uterine cancer	0.000345	0.000606	CcSEcCtD
Felbamate—Mood swings—Doxorubicin—uterine cancer	0.000345	0.000606	CcSEcCtD
Felbamate—Infection—Etoposide—uterine cancer	0.000343	0.000602	CcSEcCtD
Felbamate—Ataxia—Doxorubicin—uterine cancer	0.000343	0.000601	CcSEcCtD
Felbamate—Asthenia—Dactinomycin—uterine cancer	0.000342	0.000601	CcSEcCtD
Felbamate—Dysphagia—Epirubicin—uterine cancer	0.00034	0.000597	CcSEcCtD
Felbamate—Asthma—Epirubicin—uterine cancer	0.00034	0.000597	CcSEcCtD
Felbamate—Dehydration—Doxorubicin—uterine cancer	0.000339	0.000595	CcSEcCtD
Felbamate—Thrombocytopenia—Etoposide—uterine cancer	0.000338	0.000593	CcSEcCtD
Felbamate—Tachycardia—Etoposide—uterine cancer	0.000337	0.000591	CcSEcCtD
Felbamate—Eosinophilia—Epirubicin—uterine cancer	0.000337	0.000591	CcSEcCtD
Felbamate—Hyperhidrosis—Etoposide—uterine cancer	0.000334	0.000586	CcSEcCtD
Felbamate—Pancreatitis—Epirubicin—uterine cancer	0.000334	0.000585	CcSEcCtD
Felbamate—Hypokalaemia—Doxorubicin—uterine cancer	0.000332	0.000582	CcSEcCtD
Felbamate—Anorexia—Etoposide—uterine cancer	0.000329	0.000577	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000328	0.000576	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000328	0.000576	CcSEcCtD
Felbamate—Diarrhoea—Dactinomycin—uterine cancer	0.000326	0.000573	CcSEcCtD
Felbamate—Pancytopenia—Epirubicin—uterine cancer	0.000323	0.000567	CcSEcCtD
Felbamate—Hypotension—Etoposide—uterine cancer	0.000323	0.000566	CcSEcCtD
Felbamate—Gastritis—Doxorubicin—uterine cancer	0.000322	0.000566	CcSEcCtD
Felbamate—Muscular weakness—Doxorubicin—uterine cancer	0.000321	0.000564	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000321	0.000564	CcSEcCtD
Felbamate—Dysuria—Epirubicin—uterine cancer	0.000318	0.000558	CcSEcCtD
Felbamate—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000316	0.000555	CcSEcCtD
Felbamate—Dysphagia—Doxorubicin—uterine cancer	0.000315	0.000553	CcSEcCtD
Felbamate—Asthma—Doxorubicin—uterine cancer	0.000315	0.000553	CcSEcCtD
Felbamate—Eosinophilia—Doxorubicin—uterine cancer	0.000312	0.000547	CcSEcCtD
Felbamate—Photosensitivity reaction—Epirubicin—uterine cancer	0.000311	0.000545	CcSEcCtD
Felbamate—Paraesthesia—Etoposide—uterine cancer	0.00031	0.000544	CcSEcCtD
Felbamate—Weight increased—Epirubicin—uterine cancer	0.00031	0.000543	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—uterine cancer	0.000309	0.000542	CcSEcCtD
Felbamate—Weight decreased—Epirubicin—uterine cancer	0.000308	0.00054	CcSEcCtD
Felbamate—Dyspnoea—Etoposide—uterine cancer	0.000308	0.00054	CcSEcCtD
Felbamate—Hyperglycaemia—Epirubicin—uterine cancer	0.000307	0.000539	CcSEcCtD
Felbamate—Somnolence—Etoposide—uterine cancer	0.000307	0.000539	CcSEcCtD
Felbamate—Pneumonia—Epirubicin—uterine cancer	0.000305	0.000536	CcSEcCtD
Felbamate—Vomiting—Dactinomycin—uterine cancer	0.000303	0.000532	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000301	0.000528	CcSEcCtD
Felbamate—Rash—Dactinomycin—uterine cancer	0.000301	0.000528	CcSEcCtD
Felbamate—Decreased appetite—Etoposide—uterine cancer	0.0003	0.000527	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—uterine cancer	0.000299	0.000525	CcSEcCtD
Felbamate—Fatigue—Etoposide—uterine cancer	0.000298	0.000522	CcSEcCtD
Felbamate—Jaundice—Epirubicin—uterine cancer	0.000296	0.000519	CcSEcCtD
Felbamate—Pain—Etoposide—uterine cancer	0.000295	0.000518	CcSEcCtD
Felbamate—Constipation—Etoposide—uterine cancer	0.000295	0.000518	CcSEcCtD
Felbamate—Urinary tract infection—Epirubicin—uterine cancer	0.000295	0.000518	CcSEcCtD
Felbamate—Conjunctivitis—Epirubicin—uterine cancer	0.000295	0.000518	CcSEcCtD
Felbamate—Dysuria—Doxorubicin—uterine cancer	0.000294	0.000517	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000293	0.000514	CcSEcCtD
Felbamate—Sweating—Epirubicin—uterine cancer	0.000291	0.00051	CcSEcCtD
Felbamate—Haematuria—Epirubicin—uterine cancer	0.000289	0.000508	CcSEcCtD
Felbamate—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000287	0.000504	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—uterine cancer	0.000287	0.000503	CcSEcCtD
Felbamate—Epistaxis—Epirubicin—uterine cancer	0.000286	0.000502	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—uterine cancer	0.000285	0.0005	CcSEcCtD
Felbamate—Sinusitis—Epirubicin—uterine cancer	0.000285	0.0005	CcSEcCtD
Felbamate—Feeling abnormal—Etoposide—uterine cancer	0.000284	0.000499	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—uterine cancer	0.000284	0.000498	CcSEcCtD
Felbamate—Nausea—Dactinomycin—uterine cancer	0.000283	0.000497	CcSEcCtD
Felbamate—Agranulocytosis—Epirubicin—uterine cancer	0.000283	0.000497	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—uterine cancer	0.000282	0.000496	CcSEcCtD
Felbamate—Gastrointestinal pain—Etoposide—uterine cancer	0.000282	0.000495	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000278	0.000488	CcSEcCtD
Felbamate—Bradycardia—Epirubicin—uterine cancer	0.000277	0.000487	CcSEcCtD
Felbamate—Urticaria—Etoposide—uterine cancer	0.000274	0.000481	CcSEcCtD
Felbamate—Haemoglobin—Epirubicin—uterine cancer	0.000274	0.00048	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—uterine cancer	0.000274	0.00048	CcSEcCtD
Felbamate—Rhinitis—Epirubicin—uterine cancer	0.000273	0.000479	CcSEcCtD
Felbamate—Abdominal pain—Etoposide—uterine cancer	0.000273	0.000479	CcSEcCtD
Felbamate—Body temperature increased—Etoposide—uterine cancer	0.000273	0.000479	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—uterine cancer	0.000273	0.000479	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—uterine cancer	0.000273	0.000479	CcSEcCtD
Felbamate—Hepatitis—Epirubicin—uterine cancer	0.000272	0.000478	CcSEcCtD
Felbamate—Haemorrhage—Epirubicin—uterine cancer	0.000272	0.000478	CcSEcCtD
Felbamate—Pharyngitis—Epirubicin—uterine cancer	0.00027	0.000474	CcSEcCtD
Felbamate—Sweating—Doxorubicin—uterine cancer	0.000269	0.000472	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—uterine cancer	0.000268	0.00047	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—uterine cancer	0.000265	0.000465	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—uterine cancer	0.000263	0.000462	CcSEcCtD
Felbamate—Visual impairment—Epirubicin—uterine cancer	0.000263	0.000461	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—uterine cancer	0.000262	0.00046	CcSEcCtD
Felbamate—Erythema multiforme—Epirubicin—uterine cancer	0.000258	0.000452	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—uterine cancer	0.000257	0.00045	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—uterine cancer	0.000253	0.000445	CcSEcCtD
Felbamate—Flushing—Epirubicin—uterine cancer	0.000253	0.000444	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—uterine cancer	0.000253	0.000443	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—uterine cancer	0.000252	0.000442	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—uterine cancer	0.000252	0.000442	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—uterine cancer	0.00025	0.000439	CcSEcCtD
Felbamate—Asthenia—Etoposide—uterine cancer	0.000248	0.000435	CcSEcCtD
Felbamate—Chills—Epirubicin—uterine cancer	0.000244	0.000429	CcSEcCtD
Felbamate—Pruritus—Etoposide—uterine cancer	0.000244	0.000429	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—uterine cancer	0.000243	0.000426	CcSEcCtD
Felbamate—Alopecia—Epirubicin—uterine cancer	0.000241	0.000422	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—uterine cancer	0.000238	0.000418	CcSEcCtD
Felbamate—Diarrhoea—Etoposide—uterine cancer	0.000236	0.000414	CcSEcCtD
Felbamate—Flushing—Doxorubicin—uterine cancer	0.000234	0.00041	CcSEcCtD
Felbamate—Flatulence—Epirubicin—uterine cancer	0.000234	0.00041	CcSEcCtD
Felbamate—Tension—Epirubicin—uterine cancer	0.000233	0.000408	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—uterine cancer	0.000232	0.000407	CcSEcCtD
Felbamate—Nervousness—Epirubicin—uterine cancer	0.00023	0.000404	CcSEcCtD
Felbamate—Dizziness—Etoposide—uterine cancer	0.000228	0.000401	CcSEcCtD
Felbamate—Chills—Doxorubicin—uterine cancer	0.000226	0.000397	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—uterine cancer	0.000223	0.000391	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—uterine cancer	0.00022	0.000386	CcSEcCtD
Felbamate—Vomiting—Etoposide—uterine cancer	0.00022	0.000385	CcSEcCtD
Felbamate—Anaemia—Epirubicin—uterine cancer	0.000219	0.000385	CcSEcCtD
Felbamate—Agitation—Epirubicin—uterine cancer	0.000218	0.000382	CcSEcCtD
Felbamate—Rash—Etoposide—uterine cancer	0.000218	0.000382	CcSEcCtD
Felbamate—Dermatitis—Etoposide—uterine cancer	0.000217	0.000382	CcSEcCtD
Felbamate—Headache—Etoposide—uterine cancer	0.000216	0.00038	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—uterine cancer	0.000216	0.000379	CcSEcCtD
Felbamate—Tension—Doxorubicin—uterine cancer	0.000215	0.000378	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—uterine cancer	0.000215	0.000377	CcSEcCtD
Felbamate—Malaise—Epirubicin—uterine cancer	0.000214	0.000375	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—uterine cancer	0.000213	0.000374	CcSEcCtD
Felbamate—Leukopenia—Epirubicin—uterine cancer	0.000212	0.000372	CcSEcCtD
Felbamate—Palpitations—Epirubicin—uterine cancer	0.00021	0.000368	CcSEcCtD
Felbamate—Cough—Epirubicin—uterine cancer	0.000207	0.000363	CcSEcCtD
Felbamate—Nausea—Etoposide—uterine cancer	0.000205	0.00036	CcSEcCtD
Felbamate—Hypertension—Epirubicin—uterine cancer	0.000205	0.000359	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—uterine cancer	0.000204	0.000357	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—uterine cancer	0.000203	0.000356	CcSEcCtD
Felbamate—Chest pain—Epirubicin—uterine cancer	0.000202	0.000354	CcSEcCtD
Felbamate—Myalgia—Epirubicin—uterine cancer	0.000202	0.000354	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—uterine cancer	0.000202	0.000354	CcSEcCtD
Felbamate—Agitation—Doxorubicin—uterine cancer	0.000202	0.000354	CcSEcCtD
Felbamate—Anxiety—Epirubicin—uterine cancer	0.000201	0.000353	CcSEcCtD
Felbamate—Discomfort—Epirubicin—uterine cancer	0.000199	0.00035	CcSEcCtD
Felbamate—Malaise—Doxorubicin—uterine cancer	0.000198	0.000347	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—uterine cancer	0.000197	0.000346	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—uterine cancer	0.000196	0.000345	CcSEcCtD
Felbamate—Confusional state—Epirubicin—uterine cancer	0.000195	0.000342	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—uterine cancer	0.000194	0.00034	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—uterine cancer	0.000194	0.00034	CcSEcCtD
Felbamate—Oedema—Epirubicin—uterine cancer	0.000194	0.00034	CcSEcCtD
Felbamate—Infection—Epirubicin—uterine cancer	0.000192	0.000337	CcSEcCtD
Felbamate—Cough—Doxorubicin—uterine cancer	0.000191	0.000336	CcSEcCtD
Felbamate—Thrombocytopenia—Epirubicin—uterine cancer	0.000189	0.000332	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—uterine cancer	0.000189	0.000332	CcSEcCtD
Felbamate—Tachycardia—Epirubicin—uterine cancer	0.000189	0.000331	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—uterine cancer	0.000187	0.000328	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—uterine cancer	0.000187	0.000328	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—uterine cancer	0.000187	0.000328	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—uterine cancer	0.000187	0.000328	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—uterine cancer	0.000186	0.000327	CcSEcCtD
Felbamate—Discomfort—Doxorubicin—uterine cancer	0.000185	0.000324	CcSEcCtD
Felbamate—Anorexia—Epirubicin—uterine cancer	0.000184	0.000324	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—uterine cancer	0.000183	0.000321	CcSEcCtD
Felbamate—Hypotension—Epirubicin—uterine cancer	0.000181	0.000317	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—uterine cancer	0.000181	0.000317	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—uterine cancer	0.000179	0.000314	CcSEcCtD
Felbamate—Oedema—Doxorubicin—uterine cancer	0.000179	0.000314	CcSEcCtD
Felbamate—Infection—Doxorubicin—uterine cancer	0.000178	0.000312	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000176	0.000309	CcSEcCtD
Felbamate—Thrombocytopenia—Doxorubicin—uterine cancer	0.000175	0.000308	CcSEcCtD
Felbamate—Insomnia—Epirubicin—uterine cancer	0.000175	0.000307	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—uterine cancer	0.000175	0.000307	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—uterine cancer	0.000174	0.000305	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—uterine cancer	0.000173	0.000304	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—uterine cancer	0.000173	0.000303	CcSEcCtD
Felbamate—Somnolence—Epirubicin—uterine cancer	0.000172	0.000302	CcSEcCtD
Felbamate—Anorexia—Doxorubicin—uterine cancer	0.000171	0.0003	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—uterine cancer	0.00017	0.000299	CcSEcCtD
Felbamate—Decreased appetite—Epirubicin—uterine cancer	0.000168	0.000295	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—uterine cancer	0.000167	0.000294	CcSEcCtD
Felbamate—Fatigue—Epirubicin—uterine cancer	0.000167	0.000293	CcSEcCtD
Felbamate—Pain—Epirubicin—uterine cancer	0.000165	0.00029	CcSEcCtD
Felbamate—Constipation—Epirubicin—uterine cancer	0.000165	0.00029	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000163	0.000286	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—uterine cancer	0.000162	0.000284	CcSEcCtD
Felbamate—Paraesthesia—Doxorubicin—uterine cancer	0.000161	0.000282	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—uterine cancer	0.00016	0.00028	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—uterine cancer	0.000159	0.00028	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—uterine cancer	0.000159	0.000279	CcSEcCtD
Felbamate—Gastrointestinal pain—Epirubicin—uterine cancer	0.000158	0.000278	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—uterine cancer	0.000158	0.000277	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—uterine cancer	0.000156	0.000273	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—uterine cancer	0.000154	0.000271	CcSEcCtD
Felbamate—Urticaria—Epirubicin—uterine cancer	0.000154	0.00027	CcSEcCtD
Felbamate—Pain—Doxorubicin—uterine cancer	0.000153	0.000269	CcSEcCtD
Felbamate—Constipation—Doxorubicin—uterine cancer	0.000153	0.000269	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—uterine cancer	0.000153	0.000268	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—uterine cancer	0.000153	0.000268	CcSEcCtD
Felbamate—Feeling abnormal—Doxorubicin—uterine cancer	0.000148	0.000259	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000146	0.000257	CcSEcCtD
Felbamate—Urticaria—Doxorubicin—uterine cancer	0.000142	0.00025	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—uterine cancer	0.000142	0.000248	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—uterine cancer	0.000142	0.000248	CcSEcCtD
Felbamate—Asthenia—Epirubicin—uterine cancer	0.000139	0.000244	CcSEcCtD
Felbamate—Pruritus—Epirubicin—uterine cancer	0.000137	0.00024	CcSEcCtD
Felbamate—Diarrhoea—Epirubicin—uterine cancer	0.000132	0.000232	CcSEcCtD
Felbamate—Asthenia—Doxorubicin—uterine cancer	0.000128	0.000225	CcSEcCtD
Felbamate—Dizziness—Epirubicin—uterine cancer	0.000128	0.000225	CcSEcCtD
Felbamate—Pruritus—Doxorubicin—uterine cancer	0.000127	0.000222	CcSEcCtD
Felbamate—Vomiting—Epirubicin—uterine cancer	0.000123	0.000216	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—uterine cancer	0.000123	0.000215	CcSEcCtD
Felbamate—Rash—Epirubicin—uterine cancer	0.000122	0.000214	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—uterine cancer	0.000122	0.000214	CcSEcCtD
Felbamate—Headache—Epirubicin—uterine cancer	0.000121	0.000213	CcSEcCtD
Felbamate—Dizziness—Doxorubicin—uterine cancer	0.000118	0.000208	CcSEcCtD
Felbamate—Nausea—Epirubicin—uterine cancer	0.000115	0.000202	CcSEcCtD
Felbamate—Vomiting—Doxorubicin—uterine cancer	0.000114	0.0002	CcSEcCtD
Felbamate—Rash—Doxorubicin—uterine cancer	0.000113	0.000198	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—uterine cancer	0.000113	0.000198	CcSEcCtD
Felbamate—Headache—Doxorubicin—uterine cancer	0.000112	0.000197	CcSEcCtD
Felbamate—Nausea—Doxorubicin—uterine cancer	0.000106	0.000187	CcSEcCtD
